Kheiron Medical Technologies
London, United Kingdom
Kheiron Medical Technologies, founded in 2016 in London, developed Mia™, an AI-powered platform for breast cancer screening. Utilizing deep learning, the solution assists radiologists in detecting cancer earlier and more accurately. Mia functions as an independent, concurrent, or triage reader within diagnostic workflows. In 2024, Kheiron was acquired by DeepHealth, a global leader in AI-powered health informatics. The company leverages advanced AI to enable operational efficiency, clinical confidence, and better care delivery. Focusing on large-scale diagnostic and screening programs, Kheiron aims to elevate the experience for care teams through intuitive technology, enhancing breast cancer detection capabilities globally.
Company Info
- Founded
- 2016
- Website
- kheironmed.com
Only accessible to MedStartr community members.
Join nowWhat do you think of Kheiron Medical Technologies?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.